Villejuif, France

Philippe G Gayral

This inventor holds 1 USPTO granted patent. Top assignee: Laboratoires Biocodex. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philippe G Gayral. Retrieved from https://idiyas.com/inventor/philippe-g-gayral

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Philippe G Gayral

Introduction

Philippe G Gayral is a notable inventor based in Villejuif, France. He has made significant contributions to the field of medicine, particularly in the treatment of amoebiasis. His innovative approach has led to the development of a unique method that utilizes yeasts for therapeutic purposes.

Latest Patents

Philippe G Gayral holds a patent for a method for the treatment of amoebiasis. This method involves administering a therapeutically effective amount of yeasts from the genus Saccharomyces to human patients suffering from amoebiasis. The yeasts are preferably lyophilized and are administered at a daily dosage level of 0.5-10 grams. The species Saccharomyces boulardii is preferred for this treatment, showcasing Gayral's focus on effective and natural solutions.

Career Highlights

Philippe G Gayral is associated with Laboratoires Biocodex, where he has been able to apply his innovative ideas in a practical setting. His work at this company has allowed him to contribute to advancements in medical treatments, particularly in gastrointestinal health.

Collaborations

Philippe has collaborated with Bernard M Hublot, further enhancing the research and development efforts within his field. Their partnership exemplifies the importance of teamwork in driving innovation and improving patient outcomes.

Conclusion

Philippe G Gayral's contributions to the treatment of amoebiasis through his patented method highlight his role as an influential inventor in the medical field. His work continues to pave the way for new therapeutic approaches that can benefit patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…